Target intelligence / Profile preview

Enolase 1 pseudogene 1 (ENO1P1)

Target
ENO1P1
Molecular classification
Other (Pseudogene; not classified as enzyme, receptor, transporter, etc.)
01

Overview

Enolase 1 pseudogene 1 (ENO1P1) is a human genomic pseudogene with high sequence similarity to the active enolase 1 (ENO1) gene. Unlike ENO1, which codes for the alpha-enolase glycolytic enzyme involved in critical cellular processes and is implicated in various cancers, ENO1P1 does not encode a functional protein, is not involved in biological pathways or disease mechanisms, and is not classified as a drug target, biomarker, or safety concern. Canonically, pseudogenes like ENO1P1 are considered non-functional genomic DNA without direct physiological role, though areas of research occasionally examine regulatory involvement of pseudogenes; however, no such role is documented for ENO1P1[3][6]. For structured data modeling or therapeutic targeting purposes, information for ENO1P1 is limited and it should not be included as a canonical therapeutic target. Where relevant, active ENO1 (alpha-enolase) itself should be used instead.

Other names
ENO1Penolase 1 pseudogene 1ENO1P1enolase 1, (alpha) pseudogene 1
02

Mechanism of action

No mechanism of action for drugs, as ENO1P1 is not a therapeutic target

03

Biological functions

Other (No known biological function; pseudogenes generally do not encode functional protein)
04

Disease associations

Other (No direct disease role for ENO1P1; ENO1, not ENO1P1, is implicated in cancer and other pathologies)

Beyond the preview

Go deeper on Enolase 1 pseudogene 1 (ENO1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enolase 1 pseudogene 1 (ENO1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call